Total Payments
$171,271
2024 Payments
$21,990
Companies
15
Transactions
234
Medicare Patients
589
Medicare Billing
$138,676
Payment Breakdown by Category
Other$77,618 (45.3%)
Consulting$54,125 (31.6%)
Travel$34,506 (20.1%)
Food & Beverage$5,019 (2.9%)
Education$2.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,213 | 29 | 39.2% |
| Consulting Fee | $54,125 | 25 | 31.6% |
| Travel and Lodging | $34,506 | 81 | 20.1% |
| Honoraria | $10,405 | 6 | 6.1% |
| Food and Beverage | $5,019 | 92 | 2.9% |
| Education | $2.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $78,479 | 118 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $30,457 | 24 | $0 (2022) |
| Zambon USA Ltd. | $26,333 | 33 | $0 (2024) |
| Merck Sharp & Dohme LLC | $13,571 | 8 | $0 (2024) |
| United Therapeutics Corporation | $11,594 | 31 | $0 (2024) |
| One Lambda, Inc. | $3,288 | 5 | $0 (2021) |
| KAMADA LTD. | $2,589 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,000 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $1,276 | 3 | $0 (2022) |
| PFIZER INC. | $700.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,990 | 23 | Merck Sharp & Dohme LLC ($12,256) |
| 2023 | $10,859 | 17 | Zambon USA Ltd. ($9,449) |
| 2022 | $14,022 | 25 | Zambon USA Ltd. ($10,096) |
| 2021 | $18,721 | 19 | Actelion Pharmaceuticals US, Inc. ($10,613) |
| 2020 | $27,654 | 38 | Insmed, Inc. ($17,906) |
| 2019 | $68,911 | 83 | Insmed, Inc. ($54,320) |
| 2018 | $2,411 | 16 | Actelion Pharmaceuticals US, Inc. ($2,291) |
| 2017 | $6,703 | 13 | United Therapeutics Corporation ($5,856) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| 09/29/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $396.00 | General |
| 09/23/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $498.95 | General |
| 09/10/2024 | KAMADA LTD. | CYTOGAM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Infectious Disease | ||||||
| 08/22/2024 | United Therapeutics Corporation | Steen Solution (Device) | Food and Beverage | In-kind items and services | $41.14 | General |
| Category: Lung Transplant | ||||||
| 07/01/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $35.79 | General |
| 06/12/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $206.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $206.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/10/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $206.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/09/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $9,992.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $37.16 | General |
| 04/19/2024 | Zambon USA Ltd. | — | Consulting Fee | Cash or cash equivalent | $5,650.00 | General |
| 04/19/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $242.02 | General |
| 04/19/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $50.00 | General |
| 04/19/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $47.50 | General |
| 04/19/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $47.50 | General |
| 04/19/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $35.00 | General |
| 04/18/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $675.20 | General |
| 04/11/2024 | Paragonix Technologies, Inc. | — | Food and Beverage | In-kind items and services | $142.92 | General |
| 04/11/2024 | Paragonix Technologies, Inc. | — | Food and Beverage | In-kind items and services | $15.26 | General |
| 04/11/2024 | Paragonix Technologies, Inc. | — | Food and Beverage | In-kind items and services | $1.86 | General |
| 01/30/2024 | Zambon USA Ltd. | — | Food and Beverage | In-kind items and services | $41.19 | General |
| 01/22/2024 | Paragonix Technologies, Inc. | SherpaPak (Device), LiverGuard, LungGuard | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: Cardiology | ||||||
| 11/30/2023 | Zambon USA Ltd. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| 11/30/2023 | Zambon USA Ltd. | — | Travel and Lodging | Cash or cash equivalent | $433.28 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 247 | 793 | $504,802 | $98,143 |
| 2022 | 4 | 71 | 248 | $144,837 | $27,072 |
| 2021 | 6 | 211 | 242 | $12,312 | $3,765 |
| 2020 | 4 | 60 | 143 | $31,548 | $9,697 |
Total Patients
589
Total Services
1,426
Medicare Billing
$138,676
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 393 | $146,307 | $43,039 | 29.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 131 | $242,743 | $25,017 | 10.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 88 | 130 | $26,920 | $16,971 | 63.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 49 | $13,230 | $3,575 | 27.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 20 | 36 | $47,496 | $3,272 | 6.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 17 | $12,869 | $2,719 | 21.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 17 | $8,908 | $2,033 | 22.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 20 | $6,329 | $1,518 | 24.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 179 | $65,518 | $16,634 | 25.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 33 | $53,223 | $6,204 | 11.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 20 | $6,203 | $2,421 | 39.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 11 | 16 | $19,893 | $1,813 | 9.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 23 | 26 | $5,790 | $2,021 | 34.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 59 | 87 | $2,088 | $567.08 | 27.2% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 27 | 27 | $972.00 | $252.62 | 26.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 12 | 12 | $792.00 | $215.04 | 27.2% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 26 | 26 | $676.00 | $179.58 | 26.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 21 | 21 | $651.00 | $167.31 | 25.7% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 15 | 15 | $540.00 | $144.90 | 26.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 15 | 15 | $465.00 | $123.90 | 26.6% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 13 | 13 | $338.00 | $92.82 | 27.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 51 | $13,107 | $4,160 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 51 | $9,096 | $2,855 | 31.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 24 | $4,680 | $1,386 | 29.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 14 | 17 | $4,665 | $1,295 | 27.7% |
About Dr. Deborah Levine, MD
Dr. Deborah Levine, MD is a Critical Care Medicine healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831206804.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Levine, MD has received a total of $171,271 in payments from pharmaceutical and medical device companies, with $21,990 received in 2024. These payments were reported across 234 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,213).
As a Medicare-enrolled provider, Levine has provided services to 589 Medicare beneficiaries, totaling 1,426 services with total Medicare billing of $138,676. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Stanford, CA
- Active Since 08/24/2006
- Last Updated 04/12/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1831206804
Products in Payments
- Arikayce (Drug) $48,238
- UPTRAVI (Drug) $25,378
- WINREVAIR (Biological) $10,611
- TYVASO (Drug) $6,132
- ORENITRAM (Drug) $3,005
- OPSUMIT (Drug) $2,647
- CYTOGAM (Drug) $2,589
- VFEND (Drug) $700.00
- OPSUMIT MACITENTAN (Drug) $152.78
- Soliris (Drug) $150.00
- SherpaPak (Device) $122.31
- REMODULIN (Drug) $60.61
- Steen Solution (Device) $41.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Stanford
Roger Mecca, M.d, M.D
Critical Care Medicine — Payments: $89,820
Critical Care Medicine $89,820
Arthur Sung, Md, MD
Critical Care Medicine — Payments: $49,571
Critical Care Medicine $49,571
Claudia Sotillo, M.d, M.D
Critical Care Medicine — Payments: $25,016
Critical Care Medicine $25,016
Rishi Raj, M.d, M.D
Critical Care Medicine — Payments: $16,217
Critical Care Medicine $16,217
Michelle Cao, Do, DO
Critical Care Medicine — Payments: $14,061
Critical Care Medicine $14,061
Dr. Stephen Ruoss, M.d, M.D
Critical Care Medicine — Payments: $13,505
Critical Care Medicine $13,505